The seed round will fund team expansion and technology development ahead of commercial launches in the UK and US.
"Our vision is to enable people with Parkinson’s and other neurodegenerative diseases and movement disorders to live healthier lives. NuRO could give patients and clinicians a much clearer picture of their condition, enabling treatment to be tuned accurately as needed. We’re excited to continue our work with leading hospitals and patient groups and to bring our technology to market."
The investment round was led by Notion Capital with backing from EQT Ventures and various industry angels.
"We’re thrilled to be working with Notion Capital and to have someone of Stephen’s calibre join our board. His experience fits perfectly with our vision to blend the worlds of banking and technology in one powerful platform,"
The oversubscribed venture round was structured under a convertible loan note with participation from existing investors.
"we’re pleased to welcome onboard our new partners at Serafund, who bring unique insights from building and backing world-class technology businesses. We’re also grateful for the support from our existing investors, who remain as convicted as ever to the vision of transforming the patient experience and pharmaceutical value chain through digitally enabling thousands of high street pharmacies."
.png)
